PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segment Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc.
erevnon.com
View articlesYou might be interested in …
Morningstar: Why We’ve Downgraded ARK Innovation
ARK Innovation ETF (ARKK) shows few signs of improving its risk management or ability to successfully navigate the challenging territory it explores. Its Morningstar Analyst Rating drops to Negative from Neutral as its People and Parent ratings both drop to Below Average from Average.
Miners higher, FTSE 100 to one-month high
Oil producers and mining firms posted solid gains in London on Thursday on an increase in commodity prices, while Associated British Foods PLC rallied after a well-received trading update. The FTSE 100 index (FTI:UK:UKX) rose […]
CFTC Orders Interactive Brokers LLC to Pay a $1.75 Million Penalty for Supervision Failures
CFTC filed and simultaneously settled charges against Interactive Brokers LLC, a registered futures commission merchant, for failing to diligently supervise the handling of its customer accounts by not adequately preparing and configuring its electronic trading system to receive negative prices and calculate margin on April 20, 2020

